Development and Manufacture of Pharmaceutical Dosage Forms for Treatment of Substance Abuse Disorders

Description

{"description":" The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the capability to carry out development of formulations, manufacture, quality control tests, stability studies and distribution of pharmaceutical drug products to be used in the medications development program for treating substance use disorders. Development of medications for the treatment of substance use disorders is a major mission of NIDA. Some of the potential treatment drugs currently being investigated are new chemical entities and previously approved drug substances. The Government acquires these drug substances from private industries, Government contractors/grantees, or independent investigators. This contract is to provide the Government a resource for the development and manufacture of pharmaceutical dosage forms for use in preclinical and clinical studies. Please see SSN attached. \n"} Solicitation Number: 75N98026R00007SB Type: Sources Sought Base Type: Sources Sought NAICS: 541715 Classification Code: AN11 Response Deadline: 2026-03-04T09:00:00-05:00 Office Address: Bethesda, MD POC: Scott Duernberger, scott.duernberger@nih.gov, 3015940670 POC: Joshua T Lazarus, josh.lazarus@nih.gov, 3018276923 {"description":" The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the capability to carry out development of formulations, manufacture, quality control tests, stability studies and distribution of pharmaceutical drug products to be used in the medications development program for treating substance use disorders. Development of medications for the treatment of substance use disorders is a major mission of NIDA. Some of the potential treatment drugs currently being investigated are new chemical entities and previously approved drug substances. The Government acquires these drug substances from private industries, Government contractors/grantees, or independent investigators. This contract is to provide the Government a resource for the development and manufacture of pharmaceutical dosage forms for use in preclinical and clinical studies. Please see SSN attached. \n"}